<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Urology</title>
            <link>https://medicalxpress.com/urology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Urology</description>

                            <item>
                    <title>Should lowest-risk prostate &#039;cancer&#039; still be called cancer? How changing the name could save lives</title>
                    <description>A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer &quot;cancer&quot; does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment and encourage more men to get screened, potentially leading to significantly fewer deaths from aggressive prostate cancer.</description>
                    <link>https://medicalxpress.com/news/2026-07-lowest-prostate-cancer.html</link>
                    <category></category>
                    <pubDate>Wed, 01 Jul 2026 16:00:11 EDT</pubDate>
                    <guid isPermaLink="false">news702131221</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/doctor.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>DNA methylation patterns may explain why some prostate cancers turn lethal</title>
                    <description>The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million American men, with another 330,000 men expected to be diagnosed with the condition this year alone.</description>
                    <link>https://medicalxpress.com/news/2026-07-dna-methylation-patterns-prostate-cancers.html</link>
                    <category></category>
                    <pubDate>Wed, 01 Jul 2026 07:40:02 EDT</pubDate>
                    <guid isPermaLink="false">news702101821</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/prostate-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Intravesical CAR T therapy opens door to bladder-sparing cancer treatment</title>
                    <description>Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The study, published in the Journal of Experimental Medicine (JEM), demonstrates that direct delivery of these CAR T cells via a catheter can control bladder tumors in mice, raising hopes that a similar approach may be effective in humans.</description>
                    <link>https://medicalxpress.com/news/2026-06-intravesical-car-therapy-door-bladder.html</link>
                    <category></category>
                    <pubDate>Fri, 26 Jun 2026 10:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news701596381</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/intravesical-car-t-the.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Developing a new methodology to identify biomarkers for male infertility</title>
                    <description>Researchers from the EHU-University of the Basque Country have developed a robust protocol to detect the molecules involved in the metabolic reactions of sperm. The new method enables a detailed analysis even with small samples and allows the detection of the largest number of potential biomarkers identified to date; this advance could help diagnose male infertility and develop future clinical solutions. The paper is published in the journal Cells.</description>
                    <link>https://medicalxpress.com/news/2026-06-methodology-biomarkers-male-infertility.html</link>
                    <category></category>
                    <pubDate>Thu, 25 Jun 2026 11:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news701603238</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/man-at-doctor-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New blood test detects more high-risk prostate cancer cases</title>
                    <description>A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the PSA test, without subjecting more men to unnecessary testing. The study is published in the Annals of Internal Medicine.</description>
                    <link>https://medicalxpress.com/news/2026-06-blood-high-prostate-cancer-cases.html</link>
                    <category></category>
                    <pubDate>Tue, 23 Jun 2026 12:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news701432549</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/blood-test-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hidden PIM1 pathway helps prostate cancer survive treatment, pointing to new drug strategy</title>
                    <description>Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.</description>
                    <link>https://medicalxpress.com/news/2026-06-hidden-pim1-pathway-prostate-cancer.html</link>
                    <category></category>
                    <pubDate>Tue, 16 Jun 2026 15:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news700838188</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/cancers-hidden-escape.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity</title>
                    <description>Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing antitumor immunity, according to a preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering.</description>
                    <link>https://medicalxpress.com/news/2026-06-experimental-treatment-prostate-tumor-cells.html</link>
                    <category></category>
                    <pubDate>Mon, 15 Jun 2026 10:00:10 EDT</pubDate>
                    <guid isPermaLink="false">news700735501</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/experimental-treatment.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Aspirin may unmask silent bladder cancer by triggering bleeding</title>
                    <description>The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause mild bleeding or worsen existing bleeding in the urinary tract. Results from a study in the Journal of Internal Medicine suggest that this may prompt a clinician to run tests to uncover an asymptomatic bladder tumor.</description>
                    <link>https://medicalxpress.com/news/2026-06-aspirin-unmask-silent-bladder-cancer.html</link>
                    <category></category>
                    <pubDate>Wed, 03 Jun 2026 03:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news699611881</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/aspirin-pills.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Immunotherapy added to radiation therapy boosts survival in localized prostate cancer</title>
                    <description>Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival for patients with intermediate- or high-risk localized prostate cancer. The study was led by researchers at the Johns Hopkins University School of Medicine, Johns Hopkins Kimmel Cancer Center, Department of Radiation Oncology and Molecular Radiation Sciences, and Brady Urological Institute. Findings from the study were published June 1 in The Lancet Oncology.</description>
                    <link>https://medicalxpress.com/news/2026-06-immunotherapy-added-therapy-boosts-survival.html</link>
                    <category></category>
                    <pubDate>Tue, 02 Jun 2026 16:40:05 EDT</pubDate>
                    <guid isPermaLink="false">news699629521</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/radiation-therapy.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows</title>
                    <description>A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination prostate cancer treatment could prevent the disease from progressing into a harder-to-treat form of cancer in select patients.</description>
                    <link>https://medicalxpress.com/news/2026-06-prostate-cancer-treatment-disease-clinical.html</link>
                    <category></category>
                    <pubDate>Tue, 02 Jun 2026 13:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news699618781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/prostate-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cannabis use does not lower testosterone, study concludes</title>
                    <description>The effects of cannabis on the hormonal system and male fertility remain controversial within the scientific community. A study conducted by the University of Geneva (UNIGE), in collaboration with the Swiss Center for Applied Human Toxicology (SCAHT), provides a new answer by showing that cannabis use does not reduce testosterone levels in young men and may even increase its testicular synthesis.</description>
                    <link>https://medicalxpress.com/news/2026-05-cannabis-testosterone.html</link>
                    <category></category>
                    <pubDate>Thu, 28 May 2026 08:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news699175982</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/cannabis-use.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
